Report Overview:

The following report titled “Global Dry Eye Syndrome Market: By Product (Artificial Tears, Anti-inflammatory drugs [Cyclosporine, Corticosteroid], Punctal Plugs [Disposable, Removable], Others), By Disease Type (Aqueous Dry Eye, Evaporative Dry Eye) and other forecast 2024-2030” provides a comprehensive analysis of the market, focusing on key details such as market size, growth trends, determinants of growth, segments covered, and the role of leading players in the industry.

Global Dry Eye Syndrome Market Summary

The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30. The growing incidence of this disease globally has been driving the demand for its drugs in the market since the historical years, and this trend is expected to flourish during the forthcoming period as well. Owing to the rise in the geriatric population, increased awareness of the diagnosis & treatment, and an upsurge in the usage of contact lenses, high screen time, etc., are some factors aiding in enhancing the market size.

Report Coverage & Details

• Forecast Period: 2024-2030
• Base Year: 2023
• Market Size in 2023: USD 5.2 Billion
• CAGR: 4.21%

Download Free PDF Brochure: -  https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html

Dry Eye Syndrome Market Driver:

Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.

Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years.

Segmentation Analysis: Dry Eye Syndrome Market

By Product

• Artificial Tears- Market Size & Forecast 2019-2030, USD Million
• Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
  • Cyclosporine-- Market Size & Forecast 2019-2030, USD Million
  • Corticosteroid-- Market Size & Forecast 2019-2030, USD Million
• Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
  • Dissolvable-- Market Size & Forecast 2019-2030, USD Million
  • Removable-- Market Size & Forecast 2019-2030, USD Million
• Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million

By Disease Type

• Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
• Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

• Offline- Market Size & Forecast 2019-2030, USD Million
  • Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
  • Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
• Online- Market Size & Forecast 2019-2030, USD Million

By Competition

• Competition Characteristics
• Market Share Analysis

By Region

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific

Access Full Report [Include Description + TOC] - https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html

Region: North America Holds a Major Market Share

Among all regions globally, North America is anticipated to dominate the Dry Eye Syndrome Market with the largest share during 2024-30..

Leading Players Analysis: Dry Eye Syndrome Market

The report provides detailed analysis of key players in the global Dry Eye Syndrome market, highlighting their strategies and competitive scenario.

• Mitotech Pharma
• ReGen Tree
• Santen Pharmaceutical
• HanAll BioPharma
• Sun Pharma
• Novaliq
• Sylentis
• Alcon
• Horus Pharma
• Johnson & Johnson
• Alderya Therapeutics
• Visufarma
• Allergan
• Prestige Consumer Health
•  

Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.

For Customized Report Inquiry: - https://www.marknteladvisors.com/query/request-customization/dry-eye-disease-drugs-market.html

Key Benefits for Stakeholders:

1. Informed Decision-Making: Access to comprehensive and insightful market research reports enables stakeholders to make well-informed decisions, leading to more strategic and successful initiatives.
2. Strategic Planning: The strategic reports provided by MarkNtel Advisors empower stakeholders to formulate robust strategies for market entry, product development, and competitive positioning.
3. Market Sizing & Forecasting: Stakeholders can benefit from accurate market sizing and forecasting data to make informed investment and resource allocation decisions, minimizing risks and maximizing returns.
4. Competitive Benchmarking: The availability of competitive benchmarking data allows stakeholders to assess their performance against industry peers, identify areas for improvement, and capitalize on strengths.
5. Identifying Investment Opportunities: Through trend analysis and industry insights, stakeholders can identify attractive investment opportunities and stay ahead in the market for better ROI.

About us

We are a well-known consulting, data analytics, and market research firm catering to a diverse clientele globally. With a strong presence in over 80 countries across regions like America, Asia-Pacific, Europe, the Middle East, and Africa, we specialize in providing strategic reports to multinational corporations, financial institutions, governments, and individuals. Our commitment to qualitative and quantitative research ensures comprehensive and insightful data delivery, establishing us as a trusted partner for informed decision-making.

Contact Information:

• Address: Office No.106, H-160, Sector 63, Noida, Uttar Pradesh - 201301, India
• Call (India): +91 120 4278433
• Call (USA): +1 628 895 8081
• Email: sales@marknteladvisors.com

Website: MarkNtel Advisors: Market Research Company